ZA945275B - Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2, and VP3 or sequences of that virus coding therefor - Google Patents

Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2, and VP3 or sequences of that virus coding therefor

Info

Publication number
ZA945275B
ZA945275B ZA945275A ZA945275A ZA945275B ZA 945275 B ZA945275 B ZA 945275B ZA 945275 A ZA945275 A ZA 945275A ZA 945275 A ZA945275 A ZA 945275A ZA 945275 B ZA945275 B ZA 945275B
Authority
ZA
South Africa
Prior art keywords
cav
virus
vaccines
induction
proteins
Prior art date
Application number
ZA945275A
Other languages
English (en)
Inventor
Mathieu Hubertus Maria Noteborn
Guus Koch
Original Assignee
Aesculaap Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aesculaap Bv filed Critical Aesculaap Bv
Publication of ZA945275B publication Critical patent/ZA945275B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/10011Circoviridae
    • C12N2750/10021Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/10011Circoviridae
    • C12N2750/10022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA945275A 1993-07-20 1994-07-19 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2, and VP3 or sequences of that virus coding therefor ZA945275B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL9301272A NL9301272A (nl) 1993-07-20 1993-07-20 Chicken Anemia Virus mutanten en vaccins en toepassingen gebaseerd op de virale eiwitten VP1, VP2 en VP3 of daarvoor coderende sequenties van dat virus.

Publications (1)

Publication Number Publication Date
ZA945275B true ZA945275B (en) 1995-02-24

Family

ID=19862681

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA945275A ZA945275B (en) 1993-07-20 1994-07-19 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2, and VP3 or sequences of that virus coding therefor

Country Status (13)

Country Link
US (1) US5952002A (fr)
EP (2) EP0784685B1 (fr)
JP (1) JP3829290B2 (fr)
AT (2) ATE236980T1 (fr)
AU (1) AU703187B2 (fr)
CA (1) CA2167578C (fr)
DE (2) DE69435117D1 (fr)
DK (2) DK0784685T3 (fr)
ES (2) ES2196032T3 (fr)
NL (1) NL9301272A (fr)
PT (2) PT1253201E (fr)
WO (1) WO1995003414A2 (fr)
ZA (1) ZA945275B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162461A (en) * 1990-09-12 2000-12-19 Leadd B.V. Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
US20080234466A1 (en) * 1990-09-12 2008-09-25 Noteborn Mathieu H M Delivery method for the tumor-specific apoptosis-inducing activity of apoptin
EP0878546A1 (fr) * 1997-04-15 1998-11-18 Leadd B.V. Véhicules de transfert de gènes exprimant la protéine VP2 induisant l'apoptose, et/ou l'apoptine
EP0872552A1 (fr) * 1997-04-15 1998-10-21 Leadd B.V. Véhicules de transfert de gènes exprimant la protéine VP2 induisant l'apoptose, et/ou l'apoptine
US5789567A (en) * 1994-07-06 1998-08-04 Cornell Research Foundation, Inc. Chicken infectious anemia virus vaccine
GB9414888D0 (en) * 1994-07-23 1994-09-14 Univ Belfast Method and composition
EP0830604B1 (fr) * 1995-06-07 2003-05-28 Leadd B.V. Utilisations de l'apoptine
NZ309172A (en) * 1995-06-07 1999-11-29 Leadd B Neutralizing conformational epitopes of chicken anemia virus
EP0927757A1 (fr) 1997-12-03 1999-07-07 Leadd B.V. Méthodes et moyens pour induire l'apoptose par interférence avec des protéines similaires à Bip
US7361730B1 (en) * 1999-03-15 2008-04-22 University Of Maryland Surface localized colligin/Hsp47 in carcinoma cells
EP1199363A1 (fr) * 2000-10-20 2002-04-24 Leadd B.V. Modifications de l' apoptine par phosphorylation
AUPR567401A0 (en) 2001-06-14 2001-07-12 University Of Melbourne, The Circovirus vaccines
MX338626B (es) 2005-12-29 2016-04-26 Boehringer Ingelheim Vetmed Uso de una composicion inmunogenica de pcv2 para producir los sintomas clinicos en cerdos.
EP1968630B1 (fr) 2005-12-29 2018-01-24 Boehringer Ingelheim Vetmedica, Inc. Compositions immunogènes pcv2 multivalentes
CN102311928B (zh) * 2011-08-25 2013-04-24 中国农业科学院哈尔滨兽医研究所 鸡贫血病毒vp1、vp2蛋白共表达的重组酵母工程菌、其构建方法及应用
RU2744193C2 (ru) 2015-10-16 2021-03-03 Канзас Стейт Юниверсити Рисерч Фаундейшн Иммуногенные композиции для иммунизации свиней против цирковируса типа 3 и способы их получения и применения
AU2017256071B2 (en) * 2016-04-26 2022-11-17 London School Of Hygiene & Tropical Medicine Reoviridae vaccine
CN113980146B (zh) * 2021-11-11 2022-09-27 扬州优邦生物药品有限公司 三聚体化鸭黄病毒E蛋白domainIII、其制备方法和运用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9002008A (nl) * 1990-09-12 1992-04-01 Stichting Centr Diergeneeskund Recombinant dna en rna en daarvan afgeleide produkten.
ZA918426B (en) * 1990-10-31 1992-12-30 Akzo Nv Chicken anemia virus vaccine and diagnostic
ZA927014B (en) * 1991-09-20 1993-03-19 Akzo Nv Chicken anaemia agent vaccine.

Also Published As

Publication number Publication date
EP0784685A2 (fr) 1997-07-23
PT784685E (pt) 2003-08-29
DK1253201T3 (da) 2008-11-17
WO1995003414A2 (fr) 1995-02-02
DE69432486T2 (de) 2004-03-04
ES2311005T3 (es) 2009-02-01
CA2167578A1 (fr) 1995-02-02
ATE236980T1 (de) 2003-04-15
JP3829290B2 (ja) 2006-10-04
EP1253201A3 (fr) 2003-01-08
DK0784685T3 (da) 2003-08-04
AU703187B2 (en) 1999-03-18
CA2167578C (fr) 2007-03-13
US5952002A (en) 1999-09-14
EP0784685B1 (fr) 2003-04-09
ES2196032T3 (es) 2003-12-16
PT1253201E (pt) 2008-10-27
DE69435117D1 (de) 2008-08-28
WO1995003414A3 (fr) 1995-03-02
JPH09504941A (ja) 1997-05-20
NL9301272A (nl) 1995-02-16
EP1253201A2 (fr) 2002-10-30
DE69432486D1 (de) 2003-05-15
EP1253201B1 (fr) 2008-07-16
AU7547394A (en) 1995-02-20
ATE401406T1 (de) 2008-08-15

Similar Documents

Publication Publication Date Title
ZA945275B (en) Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2, and VP3 or sequences of that virus coding therefor
BR9712592A (pt) Processo para gerar um clone infeccioso, ácido nucléico recombinante, molécula do mesmo, vìrus de rna modificado, célula infectada com o mesmo, vacina, proteìna e/ou antìgeno, e, ensaio diagnóstico
DE69536039D1 (de) Wirtszelle enthaltend ein rekombinantes Virus, welches ein Antigen exprimiert und ein rekombinantes Virus, welches ein immunstimulatorisches Molekül exprimiert
GR3035458T3 (en) Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule
CY1115749T1 (el) Κυκλοϊος χοιρων, νουκλεϊνικα οξεα, πολυπεπτιδια και εμβολια
EP0837928A4 (fr) Cytomegalovirus-poxvirus de recombinaison, compositions et utilisations
BR7908410A (pt) Meio para deteccao de anticorpos de vhb no soro do sangue,e processo para deteccao da presenca da infeccao por virus da hepatite b em seres humanos
DE69536138D1 (de) Rekombinantes Herpesvirus aus Truthähnen und seine Verwendungen
AU3069889A (en) Pox virus vectors
GR860914B (en) Expression of immunologically reactive viral proteins
MXPA03002751A (es) Fragmentos polipeptidicos del virus de la hepatitis e, composicion de vacuna y equipos de diagnostico que comprenden los mismos.
DE3853139D1 (de) Rekombinanter, fremde gene enthaltender menschlicher cytomegalovirus und seine verwendung.
EP0294469A4 (fr) Vaccins et analyses diagnostiques pour l'haemophilus influenzae.
DK0491824T3 (da) Humane parvovirus B19-proteiner og viruslignende partikler, deres fremstilling og deres anvendelse til diagnostiske bestemmelser og vacciner
EP0236977A3 (fr) Vaccins contre la diarrhée bovine virale et le choléra porcin
AU3379693A (en) Vaccines and diagnostic assays for haemophilus influenzae
DE69332264D1 (de) Mutanten des infektiösen rinder rhinotracheitis-virus und impfstoffe
NZ309172A (en) Neutralizing conformational epitopes of chicken anemia virus
EP0257721A3 (en) Vaccine
AU686000B2 (en) Infectious peritonitis vaccine
ATE122096T1 (de) Von babesia abgeleitete antigene und polypeptide (12d3-antigen).
Young Synthetic peptides as antigens: Ciba Foundation Symposium 119, John Wiley & Sons, 1986, 307 pp., ISBN 0471-998-389,£ 27.50